Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Nov 02, 2019 10:10pm

186 Views

Post# 30301740

RE:RE:RE:RE:NAIDA Director statesd short encouraging Tesamorelin words

Actually, it was qwerty22 that found the link to the source, but thanks. Seems like a comment like that from the NIAID Director should carry some weight with the FDA. Can THTX take both the NIAID Director AND Dr. Grinspoon to the FDA meeting with them?

-LT

Unomas69 wrote: LT... I forgot to place the source in my file but notice LongTerm was able to locate the exact source that I had. I like to read a lot and tend to have a lot of medical and science subscriptions. I am fortunate to have a nephew that likes computers and coding and he has designed a search engine type to bird dog to hunt key words 24/7. Thanks LongTerm for you help.

Bullboard Posts

Canadians having more difficulty saving for retirement, study finds